Clinical Trials
30 trialsNCT06251310 2026-05-08
SW-682 in Advanced Solid Tumors
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 1 Recruiting
NCT04442022 2026-05-06
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Karyopharm Therapeutics Inc
Phase 2/3 Active not recruiting
NCT07393477 2026-02-06
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
Sir Run Run Shaw Hospital
Phase 2 Not yet recruiting
NCT05957081 2025-12-30
MarkV-01
PharmAbcine
Phase 1 Recruiting
NCT03556228 2025-12-11
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
Phase 1/2 Recruiting
NCT07142421 2025-08-26
A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma
First Affiliated Hospital of Zhejiang University
Phase 2 Active not recruiting
NCT06013618 2025-06-17
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Sun Yat-sen University
Phase 2 Recruiting
NCT03034473 2023-12-28
TransValid-A
University Medical Center Goettingen
Phase NA Unknown
NCT05228951 2022-09-13
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
Shengjing Hospital
Phase 2 Recruiting
NCT04486911 2022-08-02
Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial
Shengjing Hospital
Phase 2 Active not recruiting
NCT05174156 2022-07-14
Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Unknown
NCT00805961 2021-12-08
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
SCRI Development Innovations, LLC
Phase 2 Completed
NCT04718701 2021-08-16
ATNPA
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT04846452 2021-08-12
Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT04942301 2021-06-30
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT03411161 2021-05-25
S 81694 Plus Paclitaxel in Metastatic Breast Cancer
Servier
Phase 1/2 Completed
NCT04413734 2020-06-04
Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma
Zhejiang University
Phase 2 Unknown
NCT04161794 2019-11-13
Multimodal Intervention for Patients With Non-small Cell Lung Cancer
Aalborg University Hospital
Phase NA Completed
NCT03138044 2019-05-14
Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma
The National Ribat University
Phase NA Unknown
NCT03580980 2018-07-10
Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries
National Cancer Institute, Egypt
Phase NA Completed
NCT03282825 2018-01-23
Clinical Study of Decitabine and Paclitaxel Combination Therapy
Dong Wha Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT02427399 2017-06-22
Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients
Fenway Community Health
Phase NA Completed
NCT01769508 2016-06-13
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
SCRI Development Innovations, LLC
Phase 2 Terminated
NCT01889420 2015-07-31
Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
New Mexico Cancer Research Alliance
Phase 1 Terminated
NCT01226719 2015-05-27
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00061984 2014-10-27
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT02165696 2014-06-17
LYMPHATIC
University of Malaga
Phase NA Unknown
NCT01379482 2014-05-06
Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer
Uppsala University
Phase 2 Completed
NCT01566994 2013-09-17
Comparing Population Cessation Services
University of Rhode Island
Phase NA Completed
NCT00652860 2011-05-16
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery
Mayo Clinic
Phase 2 Completed